526
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Type II diabetes mellitus and menopause: a multinational study

, , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 663-672 | Received 25 Mar 2013, Accepted 18 Apr 2013, Published online: 06 Jun 2013
 

Abstract

Background Type II diabetes mellitus causes metabolic changes that may lead to early menopause and worsen climacteric symptoms.

Objectives To determine the risk factors for type II diabetes mellitus and assess the impact of this disease on the age of menopause and on climacteric symptoms.

Methods A total of 6079 women aged between 40 and 59 years from 11 Latin American countries were requested to answer the Menopause Rating Scale and Goldberg Anxiety-Depression Scale.

Results The prevalence of diabetes was 6.7%. Diabetes mellitus was associated with arterial hypertension (odds ratio (OR) 4.49; 95% confidence interval (CI) 3.47–5.31), the use of psychotropic drugs (OR 1.54; 95% CI 1.22–1.94), hormonal therapy (OR 1.46; 95% CI 1.11–1.92), ≥ 50 years of age (OR 1.48; 95% CI 1.17–1.86), overweight or obese (OR 1.47; 95% CI 1.15–1.89), and waist circumference ≥ 88 cm (OR 1.32; 95% CI 1.06–1.65). Factors associated with lower risk of diabetes were the use of hormonal contraceptives (OR 0.55; 95% CI 0.35–0.87), alcohol (OR 0.73; 95% CI 0.54–0.98) and living in cities > 2500 meters above sea level (OR 0.70; 95% CI 0.53–0.91) or with high temperatures (OR 0.67; 95% CI 0.51–0.88). In turn, diabetes tripled the risk of menopause in women under 45 years of age. Diabetes did not increase the risk of deterioration of quality of life due to climacteric symptoms.

Conclusion Menopause does not increase the risk of type II diabetes mellitus. Diabetes is associated with early menopause in women under 45 years of age.

Conflict of interest The authors report no conflict of interest. The authors alone are responsible for the content and writing of this paper.

Source of funding Nil.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.